UK Markets close in 44 mins
  • FTSE 100

    6,359.90
    -3.03 (-0.05%)
     
  • FTSE 250

    19,254.23
    -142.11 (-0.73%)
     
  • AIM

    1,040.00
    +1.97 (+0.19%)
     
  • GBP/EUR

    1.1182
    -0.0029 (-0.26%)
     
  • GBP/USD

    1.3361
    +0.0004 (+0.0334%)
     
  • BTC-GBP

    12,426.60
    -254.53 (-2.01%)
     
  • CMC Crypto 200

    324.65
    -12.84 (-3.81%)
     
  • S&P 500

    3,642.21
    +12.56 (+0.35%)
     
  • DOW

    29,926.75
    +54.28 (+0.18%)
     
  • CRUDE OIL

    45.24
    -0.47 (-1.03%)
     
  • GOLD FUTURES

    1,786.40
    -24.80 (-1.37%)
     
  • NIKKEI 225

    26,644.71
    +107.40 (+0.40%)
     
  • HANG SENG

    26,894.68
    +75.23 (+0.28%)
     
  • DAX

    13,348.69
    +62.12 (+0.47%)
     
  • CAC 40

    5,602.38
    +35.59 (+0.64%)
     

Global Imaging Agents Market Analysis 2020: Providing Brighter and Clearer Images for Effective Clinical Diagnosis

Research and Markets
·4-min read

Dublin, Nov. 02, 2020 (GLOBE NEWSWIRE) -- The "Imaging Agents - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Imaging Agents estimated at US$10.4 Billion in the year 2020, is projected to reach a revised size of US$12.9 Billion by 2027, growing at a CAGR of 3.1% over the analysis period 2020-2027. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is projected to record a 3.5% CAGR and reach US$6.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the X-Ray/CT segment is readjusted to a revised 2.6% CAGR for the next 7-year period.

The Imaging Agents market in the U.S. is estimated at US$2.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2027 trailing a CAGR of 5.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.8% and 2.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

In the global MRI segment, USA, Canada, Japan, China and Europe will drive the 2.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1 Billion in the year 2020 will reach a projected size of US$1.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2027, while Latin America will expand at a 3.7% CAGR through the analysis period.

This report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • Aytu BioScience Inc.

  • Bayer Healthcare Pharmaceuticals

  • Bracco Diagnostics Inc.

  • Curium

  • Daiichi Sankyo Company Limited

  • Eli Lilly

  • GE Healthcare

  • Guerbet Group

  • Lantheus Medical Imaging Inc.

  • Piramal Imaging SA


Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Imaging Agents: Providing Brighter and Clearer Images for Effective Clinical Diagnosis

  • Recent Market Activity

  • Major Growth Drivers in a Nutshell

  • Growing Need for Early Disease Diagnosis Fosters Demand for Imaging Agents

  • Select Market Growth Restraints

  • Contrast Media: Giving Way to Contemporary Offshoots

  • X-ray/CT Segment Continues to Lead Contrast Media Market

  • Developed Economies Face Threat from Rising Demand for Contrast Agents in Asia-Pacific

  • Diagnostic Radiopharmaceuticals to Outdo Contrast Media

  • Nuclear Medicine: A Potential Growth Avenue for Dx Radiopharmaceuticals

  • Select PET and SPECT Radioisotopes Used in Nuclear Medicine

  • Select Cardiology and Oncology Radiopharmaceuticals

  • Developed Markets Rule the Imaging Agents Market, Developing Regions to Spearhead Future Growth

  • Global Competitor Market Shares

  • Imaging Agents Competitor Market Share Scenario Worldwide (in %): 2018 & 2029

  • Impact of Covid-19 and a Looming Global Recession


2. FOCUS ON SELECT PLAYERS

  • Aytu BioScience, Inc. (USA)

  • Bayer Healthcare Pharmaceuticals (Germany)

  • Bracco Diagnostics, Inc. (USA)

  • Curium (France)

  • Daiichi Sankyo Company Limited (Japan)

  • Bracco-Eisai Co., Ltd (Japan)

  • Eli Lilly and Company (USA)

  • GE Healthcare (UK)

  • Guerbet Group (France)

  • Lantheus Medical Imaging, Inc. (USA)

  • Piramal Imaging SA (Switzerland)


3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION


For more information about this report visit https://www.researchandmarkets.com/r/8txwpf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900